The contraceptives market in Guatemala, focusing on products based on hormones or spermicides, witnessed fluctuations from 2013 to 2023. The market value reached its peak in 2016 with a notable rise, followed by a steady decline starting in 2017. Over the last two years, the market continued to shrink, reflecting negative growth rates of -8.78% and -9.52% respectively. As of 2023, the market value stood at $20.869 million, showing a CAGR of -9.55% over the last five years, indicating persistent decrease.
Looking ahead, potential trends to watch for include demographic shifts, healthcare policies, and increased awareness or adoption of alternative contraceptive methods which could impact market dynamics. Economic conditions and educational campaigns may also play a significant role in shaping future demand for these products.
- Focus on demographic and economic changes
- Impact of healthcare policies and alternative methods
- Importance of educational campaigns and awareness programs
How does Guatemala rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | View data |
| 9 | 9 Ukraine | 42,988,000 | 2023 | -0.81% | -0.71% | View data |
| 10 | 10 New Zealand | 28,129,000 | 2023 | +2.59% | +3.2% | View data |
| 11 | 11 Guatemala | 20,869,000 | 2023 | -9.52% | -9.55% | |
| 12 | 12 France | 16,955,000 | 2023 | -61.67% | -36.31% | View data |
| 13 | 13 Slovenia | 14,356,000 | 2023 | -0.84% | -0.67% | View data |
